Kangmei Pharma | 600518 - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 447K 138K 2026-03
Avita Medical AUD 19.03M 1.95M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Genomma Lab Internacional MXN 1.97B 262.9M 2026-06
Hypermarcas BRL 554.5M 201.69M 2026-03
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
IQVIA Holdings USD 574M 72M 2026-06
Jiangsu Hengrui CNY 2.78B 30.09M 2026-06
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Moderna USD 216M 43M 2026-06
Organon & Co USD 434M 10M 2026-06
Revvity USD 278.58M 24.69M 2026-06
Sh Fosun Pharma CNY 3.35B 74.31M 2026-06
Tectonic Therapeutic USD 6.43M 2.99M 2026-03
Viatris USD 1.13B 205.7M 2026-06
Wuxi Apptec CNY 989.51M 97.71M 2026-06
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03
Zz Pientze Pharmaceu CNY 223.14M 8.82M 2026-06